Patient perspectives on telemedicine use in rheumatology during the COVID-19 pandemic: survey results from the COVID-19 Global Rheumatology Alliance

• Published in: Clinical rheumatology 2024, Vol.43 (1), p.543-552
• Main Authors: Maheswaranathan, Mithu, Miller, Bruce, Ung, Natasha, Sinha, Rashmi, Harrison, Carly, Egeli, Bugra Han, Degirmenci, Huseyin Berk, Sirotich, Emily, Liew, Jean W., Grainger, Rebecca, Chock, Eugenia Y.
• Format: Article
• Language: English
• Subjects: Adult; COVID-19; Female; Humans; Male; Medicine; Medicine & Public Health; Middle Aged; Original Article; Pandemics; Rheumatic diseases; Rheumatic Diseases - therapy; Rheumatology; Surveys; Telemedicine
• ISSN: 0770-3198; 1434-9949
• DOI: 10.1007/s10067-023-06717-2

Objective The COVID-19 pandemic resulted in rapid adoption of telemedicine in rheumatology. We described perspectives of patients with rheumatic diseases related to telemedicine use. Methods An anonymous online survey for people with rheumatic diseases was launched in January 2021. We collected data on reasons for telemedicine use, perceived benefits, disadvantages and obstacles of telemedicine, perceived telemedicine effectiveness for different clinical tasks, level of satisfaction with telemedicine use, and future preferences for telemedicine. We summarized results with descriptive statistics and identified themes in free text responses to describe perspectives of telemedicine qualitatively. Results We received 596 complete responses (85% female and 47% 41–60 years old). During the COVID-19 pandemic, 78% (467/596) of respondents used telemedicine, and 61% (283/467) of telemedicine users reported that telemedicine was as effective or more effective than an in-person visit. Younger participants and those in North America reported effectiveness and satisfaction with telemedicine at higher frequencies. Participants reported similar effectiveness to in-person visits for making medication changes and discussing disease symptoms or complications. Conclusion Most respondents found telemedicine at least as effective as in-person visits. Participants found telemedicine to be effective for specific scenarios, such as making medication changes and discussion of disease activity. Telemedicine may continue to be of importance in the care of patients with rheumatic diseases post pandemic, but likely for specific subsets of patients for specific visit indications. Key Points • Most patients with rheumatic disease found telemedicine as effective as in-person visits, particularly for some indications.